Originally Posted on ContractPharma on April 26th, 2022 | Read the full story here
As the Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) focused on addressing the challenges associated with manufacturing advanced therapies, continues its rapid growth, the organization wanted to install an Enterprise Resource Planning (ERP) system to support its continued expansion and provide the highest level of responsive service to clients.
CBM’s Chief Executive Officer, Joerg Ahlgrimm pointed to the rapid growth CBM is currently undergoing with 700,000 square feet of the ongoing build as one reason for the need for a robust ERP. This year, CBM selected SAP Business ByDesign, as a GMP validated system that covers the organization’s finances, client project management, supply chain planning, logistics, warehousing, manufacturing, and quality and procurement.
“We decided we needed to put in the right foundational platforms as early as possible,” Ahlgrimm said. In order to put that system in place as hassle-free as possible, CBM turned to Utah-based Navigator Business Solutions to support their efforts. “Navigator helped us do this the right way.”
Audrey Greenberg, Co-founder of CBM, agreed, saying that Navigator’s knowledge of cloud-based systems was of utmost importance to CBM when it was shopping around for implementation partners.
Navigator was instrumental in the implementation of the Enterprise Resource Planning (ERP) system covering, Finance, Client Project Management, Procurement, Supply Chain Planning, Warehousing & Logistics, Manufacturing, and Quality. This implementation is part of a multitiered strategy CBM is deploying to set up a strong foundation to execute its growth plans. Automation, digitalization, business process excellence, and technology innovation are key success factors CBM is using to build the largest end-to-end CDMO for Advanced Therapies.
“With a validated and scalable ERP system, the company is advancing its vision to build the world’s largest cell and gene therapy manufacturing and testing facility and enable the rapid development and delivery of groundbreaking treatments for patients,” said Peter Carbone, Chief Operating Officer, Center for Breakthrough Medicines. “Navigator executed the work on time and on budget and has proven to be an invaluable partner in our corporate development.”